These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15832557)

  • 21. In vitro interactions of itraconazole and micafungin against clinically important filamentous fungi.
    Ruíz-Cendoya M; Rodriguez MM; Mariné M; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2008 Nov; 32(5):418-20. PubMed ID: 18762407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
    Barchiesi F; Spreghini E; Maracci M; Fothergill AW; Baldassarri I; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3317-22. PubMed ID: 15328091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for synergistic activity of plant-derived essential oils against fungal pathogens of food.
    Hossain F; Follett P; Dang Vu K; Harich M; Salmieri S; Lacroix M
    Food Microbiol; 2016 Feb; 53(Pt B):24-30. PubMed ID: 26678126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
    Carrillo-Muñoz AJ; Ruesga M; Brio S; del Valle O; Rodriguez V; Santos P; Hernández-Molina JM; Cantón E; Pemán J; Guarro J; Quindós G
    Chemotherapy; 2002 Dec; 48(5):224-31. PubMed ID: 12476038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro synergy and antagonism of antifungal agents against yeast-like fungi.
    Dupont B; Drouhet E
    Postgrad Med J; 1979 Sep; 55(647):683-6. PubMed ID: 523360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of calcium channel blockers in combination with conventional antifungal agents against clinically important filamentous fungi.
    Homa M; Hegedűs K; Fülöp Á; Wolfárt V; Kadaikunnan S; Khaled JM; Alharbi NS; Vágvölgyi C; Galgóczy L
    Acta Biol Hung; 2017 Sep; 68(3):334-344. PubMed ID: 28901803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Najvar LK; Bocanegra R; Caselli F; Di Cesare S; Giannini D; Di Francesco LF; Giacometti A; Carle F; Scalise G; Graybill JR
    Antimicrob Agents Chemother; 2001 May; 45(5):1355-9. PubMed ID: 11302795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzon A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):917-21. PubMed ID: 16495251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
    Heller I; Leitner S; Dierich MP; Lass-Flörl C
    Int J Antimicrob Agents; 2004 Oct; 24(4):401-4. PubMed ID: 15380269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
    Biswas C; Sorrell TC; Djordjevic JT; Zuo X; Jolliffe KA; Chen SC
    J Antimicrob Chemother; 2013 Dec; 68(12):2842-6. PubMed ID: 23861311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of paper gradient concentration strips for antifungal combination testing of Candida spp.
    Siopi M; Siafakas N; Zerva L; Meletiadis J
    Mycoses; 2015 Nov; 58(11):679-87. PubMed ID: 26423198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interactions of amantadine hydrochloride, R-(-)-deprenyl hydrochloride and valproic acid sodium salt with antifungal agents against filamentous fungal species causing central nervous system infection.
    Galgóczy L; Tóth L; Virágh M; Papp T; Vágvölgyi CS
    Acta Biol Hung; 2012 Dec; 63(4):490-500. PubMed ID: 23134606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods.
    Ben-Ami R; Lewis RE; Kontoyiannis DP
    Med Mycol; 2011 Apr; 49(3):285-8. PubMed ID: 21028945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
    Cuenca-Estrella M; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Gomez-Lopez A; Buitrago MJ; Mellado E; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism.
    Kashif M; Andersson C; Mansoori S; Larsson R; Nygren P; Gustafsson MG
    Oncotarget; 2017 Nov; 8(61):103952-103967. PubMed ID: 29262612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.